Rituximab for follicular non-Hodgkin lymphoma.
Gajraj, Elangovan
Rituximab for follicular non-Hodgkin lymphoma. [electronic resource] - The Lancet. Oncology Apr 2008 - 320-1 p. digital
Publication Type: News
1474-5488
10.1016/S1470-2045(08)70036-6 doi
Antibodies, Monoclonal--therapeutic use
Antibodies, Monoclonal, Murine-Derived
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Clinical Trials as Topic
Evaluation Studies as Topic
Female
Humans
Lymphoma, Follicular--diagnosis
Male
Prognosis
Remission Induction
Rituximab
Sensitivity and Specificity
Severity of Illness Index
Societies, Medical
Survival Analysis
Treatment Outcome
United Kingdom
Rituximab for follicular non-Hodgkin lymphoma. [electronic resource] - The Lancet. Oncology Apr 2008 - 320-1 p. digital
Publication Type: News
1474-5488
10.1016/S1470-2045(08)70036-6 doi
Antibodies, Monoclonal--therapeutic use
Antibodies, Monoclonal, Murine-Derived
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Clinical Trials as Topic
Evaluation Studies as Topic
Female
Humans
Lymphoma, Follicular--diagnosis
Male
Prognosis
Remission Induction
Rituximab
Sensitivity and Specificity
Severity of Illness Index
Societies, Medical
Survival Analysis
Treatment Outcome
United Kingdom